- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.69 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 2 residues within 4Å:- Chain A: D.138, E.139
Ligand excluded by PLIPEDO.5: 3 residues within 4Å:- Chain A: P.251, G.253, E.254
Ligand excluded by PLIPEDO.6: 7 residues within 4Å:- Chain A: D.123, Y.124, I.125, A.126, T.135, A.136, A.137
Ligand excluded by PLIPEDO.7: 8 residues within 4Å:- Chain A: G.208, G.237, D.239, T.241, F.242, Q.243
- Chain B: R.13, H.14
Ligand excluded by PLIPEDO.8: 3 residues within 4Å:- Chain A: W.275, E.276
- Ligands: EDO.11
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: Y.86, Y.119, R.122, D.123, Y.124, D.138
- Ligands: EDO.14
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: R.36, E.47, P.48, R.49
Ligand excluded by PLIPEDO.11: 2 residues within 4Å:- Chain A: P.277
- Ligands: EDO.8
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: Q.33, R.49
- Ligands: EDO.23
Ligand excluded by PLIPEDO.13: 8 residues within 4Å:- Chain A: M.6, Y.8, Q.64, R.67, Y.160, S.168, Y.172
- Ligands: EKG.16
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: Q.88, Y.119, D.120, R.122
- Ligands: EDO.9
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: F.9, Y.28, D.30, D.31
- Chain B: Y.64
- Ligands: EDO.22
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain A: F.9, M.99, Q.116
- Chain B: F.57, S.58, K.59, W.61
Ligand excluded by PLIPEDO.18: 8 residues within 4Å:- Chain A: W.205, L.207, R.235, Q.243
- Chain B: Y.11, S.12, H.14, P.15
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain B: E.37, D.39, R.82, V.83, N.84, P.91
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain A: R.22, I.24
- Chain B: H.52, S.53, D.54, L.55
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain A: G.121, R.122
- Chain B: R.4, D.60
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain B: Y.27, S.58, Y.64
- Ligands: EDO.15
Ligand excluded by PLIPEDO.23: 6 residues within 4Å:- Chain A: Y.28, P.236
- Chain B: S.53, Y.64, L.66
- Ligands: EDO.12
Ligand excluded by PLIP- 1 x EKG: (2R)-2,3-dihydroxypropyl hexadecanoate(Non-covalent)
EKG.16: 14 residues within 4Å:- Chain A: Y.8, F.23, V.25, R.67, V.68, A.71, F.75, T.98, M.99, S.100, Q.156, W.157, Y.160
- Ligands: EDO.13
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:Y.8, A:Y.8, A:Y.8, A:F.23, A:V.25, A:V.68, A:A.71, A:F.75, A:F.75, A:W.157, A:Y.160
- Hydrogen bonds: A:Q.156
- Salt bridges: A:R.67
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shima, Y. et al., Crystal structures of lysophospholipid-bound MHC class I molecules. J.Biol.Chem. (2020)
- Release Date
- 2020-04-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.69 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 3 x ZN: ZINC ION(Non-covalent)
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x EKG: (2R)-2,3-dihydroxypropyl hexadecanoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shima, Y. et al., Crystal structures of lysophospholipid-bound MHC class I molecules. J.Biol.Chem. (2020)
- Release Date
- 2020-04-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D